Product Code: CDH FDA class 1 21 CFR 862.1775

Acid, Uric, Phosphotungstate Reduction

Clinical Chemistry

The Phosphotungstate Reduction Uric Acid Test is a clinical chemistry device that measures uric acid concentration in blood or urine using a colorimetric reaction in which uric acid reduces phosphotungstic acid to produce a blue color proportional to the uric acid content, used in the diagnosis and monitoring of gout and hyperuricemia. It is classified as FDA Class 1 (lowest risk), subject only to general controls, and is exempt from premarket notification. The product code is CDH, regulated under 21 CFR 862.1775, within the Clinical Chemistry medical specialty. No special flags apply to this device.

510(k)s
15
FEI Numbers
0
Registration Numbers
0
Unique Applicants
14
Years Active
9

Basic Information

Product Code
CDH
Device Class
FDA class 1
Regulation Number
862.1775
Medical Specialty
Clinical Chemistry
Review Panel
CH
Submission Type
4

Device Characteristics

GMP Exempt
Implant
Life Sustain/Support
Third Party
Summary Malfunction Reporting

510(k) Clearance History

Loading...

Related 510(k) Clearances

This FDA classification is associated with 15 510(k) clearances via K numbers.

K Number Device Name
K850933 URIC ACID
K841067 URIC ACID REAGENT SET
K821213 URIC ACID REAGENT SET
K813076 PHOSPHOTUNGSTATE REDUCTION, URIC ACID
K810088 URIC ACID (TPTZ) COLORINMETRIC
K800672 SMAC REPLACEMENT REAGENTS/DETERM-URIC-AC
K800190 STANBIO DIRECT URIC ACID TEST SET #0770
K792412 ELVI URIC ACID
K792403 ELVI URIC ACID-COLORIMETRIC METHOD
K790019 SERUM, URIC ACID DETERMINATION
K772082 ENZAC URIC ACID 100-TEST KIT
K771842 URIC ACID
K770564 URIC ACID TEST KIT
K770459 URIC ACID PROCEDURE, TEKPOINT DIRECT
K760477 REAGENTS-4 FOR URIC ACID DETERMINATION